Klinikum Darmstadt
About Klinikum Darmstadt
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Ulm
7
Celgene
3
German High-Grade Non-Hodgkin's Lymphoma Study Group
3
Boston Scientific Corporation
2
University Hospital Tuebingen
2
Universitätsklinikum Hamburg-Eppendorf
2
AGO Research GmbH
1
AIO-Studien-gGmbH
1
Aesculap AG
1
Allergan
1
Allergopharma GmbH & Co. KG
1
Clinical Trials at Klinikum Darmstadt
During the past decade, Klinikum Darmstadt conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 1 clinical trials were completed, i.e. on
average, 5.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia
2005-11-01
2011-03-01
Completed
195
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction
2006-10-01
2010-01-01
Completed
337
Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a Pollen and Dust Mite Mixture.
2007-03-01
2010-11-01
Completed
The Paclitaxel-Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) - Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions
2008-02-01
2014-03-01
Completed
48
CrossBoss and Stingray Catheter and Entera Guidewire Chronic Total Occlusion (CTO) Study
2008-09-01
2009-09-01
Completed
42
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinikum Darmstadt" #1 sponsor was "University of Ulm" with 7 trials, followed by "Celgene" with 3 trials
sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored and "University Hospital Tuebingen"
with 2 trials sponsored. Other sponsors include 22 different institutions and
companies that sponsored additional 31 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Darmstadt"
#1 collaborator was "Klinikum Darmstadt" with 2 trials as a collaborator, "Klinikum Stuttgart" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "Asahi Intecc Co., Ltd." with 1 trials as a collaborator. Other collaborators include 41 different institutions and companies that were
collaborators in the rest 51 trials.
Clinical Trials Conditions at Klinikum Darmstadt
According to Clinical.Site data, the most researched conditions in "Klinikum Darmstadt" are
"Acute Myeloid Leukemia" (3 trials), "Acute Myeloid Leukemia (AML)" (3 trials), "Crohn Disease" (3 trials), "Lymphoma" (3 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Klinikum Darmstadt" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Darmstadt
Most popular intervention types in "Klinikum Darmstadt" are "Drug" (27 trials), "Device" (8 trials), "Biological" (7 trials), "Other" (5 trials) and "Radiation" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Cytarabine" (4 trials), "Ozanimod" (3 trials), "cyclophosphamide" (3 trials) and "doxorubicin hydrochloride" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Darmstadt
The vast majority of trials in "Klinikum Darmstadt" are
42 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Klinikum Darmstadt
Currently, there are NaN active trials in "Klinikum Darmstadt".
undefined are not yet recruiting,
10 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 25 completed trials in Klinikum Darmstadt,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Darmstadt, 2 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 17 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 6 trials that are defined as “Not Applicable".
Departments of Klinikum Darmstadt
Klinikum Darmstadt has several departments that took part in Clinical trials: "Klinikum Darmstadt GmbH; Med. Klinik V; Onkologie & Hämatologie" - 5 trials, "Onkologisches Studienzentrum Darmstadt" - 2 trials
Departments List
Name
City
Trials